- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 19, 2025 | 274.83M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Investments restated | Q1 2025 · Mar 31, 2024 | $560.83M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.22B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $4.27B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $7.54B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $8.43B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $12.13B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $13.08B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 272.03M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $206.34M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $257.87M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.64 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.64 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $17.89M |
| Net Income | Q1 2025 · Mar 31, 2024 | $174.46M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $257.61M |